Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 84 results:
Author [ Title(Desc)] Type Year
Filters: Author is Cooper, C.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
D. Prieto-Alhambra, Javaid, M. K., Maskell, J., Judge, A., Nevitt, M., Cooper, C., and Arden, N. K., Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study, Ann Rheum Dis, vol. 70, pp. 134-8, 2011.
C. J. Edwards, Arden, N. K., Fisher, D., Saperia, J. C., Reading, I., van Staa, T. P., and Cooper, C., The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database, Rheumatology (Oxford), vol. 44, pp. 1394-8, 2005.
T. P. van Staa, Cooper, C., Leufkens, H. G., and Bishop, N., Children and the risk of fractures caused by oral corticosteroids, J Bone Miner Res, vol. 18, pp. 913-8, 2003.
T. P. van Staa, Geusens, P., Bijlsma, J. W., Leufkens, H. G., and Cooper, C., Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis, Arthritis Rheum, vol. 54, pp. 3104-12, 2006.
S. Khalid, Calderon-Larranaga, S., Hawley, S., Ali, M. S., Judge, A., Arden, N., Van Staa, T., Cooper, C., Javaid, M. K., and Prieto-Alhambra, D., Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database, Clin Epidemiol, vol. 10, pp. 1417-1431, 2018.
J. Leal, Gray, A. M., Hawley, S., Prieto-Alhambra, D., Delmestri, A., Arden, N. K., Cooper, C., Javaid, M. K., and Judge, A., Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study, J Bone Miner Res, vol. 32, pp. 203-211, 2017.
E
G. Wallace, Judge, A., Prieto-Alhambra, D., de Vries, F., Arden, N. K., and Cooper, C., The effect of body mass index on the risk of post-operative complications during the 6 months following total hip replacement or total knee replacement surgery, Osteoarthritis Cartilage, vol. 22, pp. 918-27, 2014.
L. E. Bayliss, Culliford, D., Monk, A. P., Glyn-Jones, S., Prieto-Alhambra, D., Judge, A., Cooper, C., Carr, A. J., Arden, N. K., Beard, D. J., and Price, A. J., The effect of patient age at intervention on risk of implant revision after total replacement of the hip or knee: a population-based cohort study, Lancet, vol. 389, pp. 1424-1430, 2017.
I. E. Bultink, Harvey, N. C., Lalmohamed, A., Cooper, C., Lems, W. F., van Staa, T. P., and de Vries, F., Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom, Osteoporos Int, vol. 25, pp. 1275-83, 2014.
C. Cooper, Dennison, E. M., Leufkens, H. G., Bishop, N., and van Staa, T. P., Epidemiology of childhood fractures in Britain: a study using the general practice research database, J Bone Miner Res, vol. 19, pp. 1976-81, 2004.
T. P. van Staa, Dennison, E. M., Leufkens, H. G., and Cooper, C., Epidemiology of fractures in England and Wales, Bone, vol. 29, pp. 517-22, 2001.
E. M. Curtis, van der Velde, R., Moon, R. J., van den Bergh, J. P., Geusens, P., de Vries, F., van Staa, T. P., Cooper, C., and Harvey, N. C., Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status, Bone, vol. 87, pp. 19-26, 2016.
C. Klop, van Staa, T. P., Cooper, C., Harvey, N. C., and de Vries, F., The epidemiology of mortality after fracture in England: variation by age, sex, time, geographic location, and ethnicity, Osteoporos Int, vol. 28, pp. 161-168, 2017.
C. Cooper, Steinbuch, M., Stevenson, R., Miday, R., and Watts, N. B., The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK, Osteoporos Int, vol. 21, pp. 569-77, 2010.
R. J. Moon, Harvey, N. C., Curtis, E. M., de Vries, F., Van Staa, T., and Cooper, C., Ethnic and geographic variations in the epidemiology of childhood fractures in the United Kingdom, Bone, vol. 85, pp. 9-14, 2016.
F
S. Pouwels, Bazelier, M. T., de Boer, A., Weber, W. E., Neef, C. K., Cooper, C., and de Vries, F., Five-year fracture risk estimation in patients with Parkinson's disease, Bone, vol. 56, pp. 266-70, 2013.
S. Pouwels, de Boer, A., Javaid, M. K., Hilton-Jones, D., Verschuuren, J., Cooper, C., Leufkens, H. G., and de Vries, F., Fracture rate in patients with myasthenia gravis: the general practice research database, Osteoporos Int, vol. 24, pp. 467-76, 2013.
D. Prieto-Alhambra, Javaid, M. K., Judge, A., Maskell, J., Kiran, A., de Vries, F., Cooper, C., and Arden, N. K., Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use, Arthritis Rheum, vol. 63, pp. 992-1001, 2011.
F. de Vries, Cooper, A. L., Cockle, S. M., van Staa, T. P., and Cooper, C., Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates, Osteoporos Int, vol. 20, pp. 1989-98, 2009.
F. de Vries, Bracke, M., Leufkens, H. G., Lammers, J. W., Cooper, C., and van Staa, T. P., Fracture risk with intermittent high-dose oral glucocorticoid therapy, Arthritis Rheum, vol. 56, pp. 208-14, 2007.
K. T. Palmer, D'Angelo, S., Harris, E. C., Linaker, C., Gale, C. R., Evandrou, M., Syddall, H., Van Staa, T., Cooper, C., A. Sayer, A., Coggon, D., and Walker-Bone, K., Frailty, prefrailty and employment outcomes in Health and Employment After Fifty (HEAF) Study, Occup Environ Med, vol. 74, pp. 476-482, 2017.
D. Culliford, Maskell, J., Judge, A., Cooper, C., Prieto-Alhambra, D., and Arden, N. K., Future projections of total hip and knee arthroplasty in the UK: results from the UK Clinical Practice Research Datalink, Osteoarthritis Cartilage, vol. 23, pp. 594-600, 2015.
I
E. Burn, Edwards, C. J., Murray, D. W., Silman, A., Cooper, C., Arden, N. K., Prieto-Alhambra, D., and Pinedo-Villanueva, R., The impact of bmi and smoking on risk of revision following knee and hip replacement surgery: evidence from routinely collected data, Osteoarthritis Cartilage, 2019.
C. J. Edwards, Cooper, C., Fisher, D., Field, M., van Staa, T. P., and Arden, N. K., The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis, Arthritis Rheum, vol. 57, pp. 1151-7, 2007.
T. P. van Staa, Selby, P., Leufkens, H. G., Lyles, K., Sprafka, J. M., and Cooper, C., Incidence and natural history of Paget's disease of bone in England and Wales, J Bone Miner Res, vol. 17, pp. 465-71, 2002.
R. Y. van der Velde, Wyers, C. E., Geusens, P., van den Bergh, J. P. W., de Vries, F., Cooper, C., van de Staa, T. P., and Harvey, N. C., Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older, Osteoporos Int, vol. 29, pp. 2469-2475, 2018.
T. P. van Staa, Geusens, P., Zhang, B., Leufkens, H. G., Boonen, A., and Cooper, C., Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids, Rheumatology (Oxford), vol. 46, pp. 460-6, 2007.
T. P. van Staa, Cooper, C., Barlow, D., and Leufkens, H. G., Individualizing the risks and benefits of postmenopausal hormone therapy, Menopause, vol. 15, pp. 374-81, 2008.
J. M. Wijnands, van Durme, C. M., Driessen, J. H., Boonen, A., Klop, C., Leufkens, B., Cooper, C., Stehouwer, C. D., and de Vries, F., Individuals With Type 2 Diabetes Mellitus Are at an Increased Risk of Gout But This Is Not Due to Diabetes: A Population-Based Cohort Study, Medicine (Baltimore), vol. 94, p. e1358, 2015.
C. Cooper, Fox, K. M., and Borer, J. S., Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case-control study in the CPRD, Osteoporos Int, vol. 25, pp. 737-45, 2014.
[Page last reviewed 4 October 2019]